SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

crow with knife is generating intense community interest due to its unique multichain presence and deflationary burn mechanism. Supporters are actively rallying behind the project's organic growth and cultural identity, frequently encouraging others to increase their positions in what they describe as a community-driven movement.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is generating massive social media buzz and extreme volatility driven by a major executive order aimed at fast-tracking psychedelic research for PTSD and addiction. Community discussion is dominated by speculation over a potential short squeeze due to the stock's low float, with many retail traders highlighting its ibogaine supply chain as a key catalyst while others debate the risks of a volatility-driven pump.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors react to the news that Greenland has approved the transfer of a majority interest in the Tanbreez project, bringing the company's total ownership to 92.5%. The community is actively discussing the potential for a significant short squeeze given the high short interest, while expressing bullish sentiment on the asset's strategic value for Western supply chains and its potential for a long-term revaluation.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant market volatility after a Blue Origin launch resulted in the BlueBird 7 satellite being placed into an unsustainably low orbit, leading to its required de-orbiting. While the company maintains that insurance will mitigate financial losses and that its broader constellation deployment roadmap remains intact, the community is actively debating the reliability of launch providers, the impact on launch cadence, and whether this setback represents a temporary operational hurdle or a deeper execution risk.

AEVEX Corp. operates as a holding company. It operates through Tactical Systems and Global Solutions segments. The Tactical Systems segment focuses on design, development, and production of autonomous systems including unmanned aerial systems and unmanned surface vessels. The Global Solutions segment offers services and mission support to defense and intelligence customers. The company was founded in 2017 and is headquartered in Solana Beach, CA.

AEVEX Corp. - Ordinary Shares - Class A

AEVEX Corp. is generating significant investor buzz following its recent NYSE IPO, with market participants closely monitoring the drone manufacturer due to its strong defense sector positioning and ongoing government contract activity. Community discussion is focused on the stock's high-volatility momentum, with traders actively comparing its growth potential to other defense technology players while debating the sustainability of its post-debut price action.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific is trending as investors focus on its pivot from Bitcoin mining to AI data center infrastructure and high-density compute hosting. The community is actively discussing the company's long-term potential supported by major power capacity contracts, alongside institutional accumulation and heavy call option activity.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster Inc. is capturing significant investor attention as it evolves into a full-stack 'Physical AI' platform following its acquisition of Stereolabs, with sentiment shifting toward its long-term potential in industrial automation, robotics, and smart infrastructure. Community discussions are currently dominated by analysis of the company's path to profitability, the strategic advantages of its sensor-software integration, and the impact of domestic sourcing policies on future market dominance.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing increased investor activity and bullish sentiment as the community anticipates critical updates on fiscal guidance, royalty backlogs, and revenue growth in upcoming financial reports. Investors are highlighting BlackBerry's pivotal role as a safety-certified foundation for physical AI and software-defined vehicles, driven by expanding partnerships with major automotive and robotics manufacturers.

Soitec SA engages in the designing and manufacturing semiconductor materials. It operates through the Electronics and Others Business segments. The Electronics segment offers services to the semiconductor sector, producing and marketing substrates and components. The Others Business segment operates in Solar Energy sector, which also provides financing activities related to the Touwsrivier solar power plant in South Africa, as well as certain ongoing maintenance activities, primarily in Europe and the United States. The company was founded by Jean-Michel Lamure and Andre-Jacques Auberton-Herve on February 27, 1992, and is headquartered in Bernin, France.

SOITEC

Investors are rallying around Soitec, viewing it as an essential supply chain bottleneck for the growing co-packaged optics and silicon photonics sectors. While some point to drag from weaker traditional segments like mobile communications, the community is largely focused on the potential for long-term growth as a critical substrate provider for major AI hardware players.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as investors rally behind its pivotal role in the AI infrastructure and semiconductor space, bolstered by strategic partnerships with major tech leaders and positive analyst sentiment. The community remains heavily focused on the company's expansion into custom AI silicon and optics, with many debating whether the current momentum represents a long-term re-rating or a temporary peak.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Acumen Pharmaceuticals (ABOS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?

Here is how Acumen Pharmaceuticals, Inc. (ABOS) and ADC Therapeutics SA (ADCT) have performed compared to their sector so far this year.

Acumen Pharmaceuticals (NASDAQ:ABOS) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised Acumen Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Sunday...

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) has been given an average rating of "Moderate Buy" by the six brokerages that are currently covering the stock, Marketbeat Ratings...

Acumen Pharmaceuticals (NASDAQ:ABOS) Receives "Buy" Rating from BTIG Research

BTIG Research reissued a "buy" rating and issued a $8.00 target price on shares of Acumen Pharmaceuticals in a report on Thursday...

Acumen Pharmaceuticals Q4 Earnings Call Highlights

Acumen Pharmaceuticals (NASDAQ:ABOS) outlined progress across its lead Alzheimer's disease program and an emerging "enhanced brain delivery" (EBD) platform during its fourth-quarter and full-year 2025 update, while management reiterated expectations for a key Phase 2 readout later in 2026 and provid...

Acumen Pharmaceuticals (NASDAQ:ABOS) Announces Earnings Results, Beats Expectations By $0.09 EPS

Acumen Pharmaceuticals (NASDAQ:ABOS - Get Free Report) released its earnings results on Thursday. The company reported ($0.41) earnings per share for the quarter, topping analysts' consensus estimates of ($0.50) by $0.09...

Acumen Pharmaceuticals (ABOS) Projected to Post Earnings on Monday

Acumen Pharmaceuticals (NASDAQ:ABOS) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-acumen-pharmaceuticals-inc-stock...

Wall Street Zen Downgrades Acumen Pharmaceuticals (NASDAQ:ABOS) to Sell

Wall Street Zen downgraded Acumen Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Saturday...

Acumen Pharmaceuticals Spotlights Sabirnetug Phase II Progress, JCR Brain-Delivery Partnership at Conference

Acumen Pharmaceuticals (NASDAQ:ABOS) executives outlined key clinical and research milestones for the company's Alzheimer's disease pipeline during a discussion focused on its lead antibody, sabirnetug, and an enhanced brain delivery (EBD) collaboration with Japan-based JCR Pharmaceuticals.

Company...

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.40	--	--	N/A
Q4 '25	-$0.46	-$0.40	12.98%	BEAT
Q3 '25	-$0.60	-$0.44	27.03%	BEAT
Q2 '25	-$0.49	-$0.68	-39.17%	MISSED
Q1 '25	-$0.73	-$0.48	33.92%	BEAT

ABOS
Acumen Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest ABOS News

ABOSAcumen Pharmaceuticals Inc